← Back to home

MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS)

Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS) explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS) trials appear

Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Hunting the clues: can scans predict deadly cancer in genetic disorder?

Knowledge-focused Ongoing

This study aims to find better ways to predict which benign nerve tumors in people with Neurofibromatosis type 1 (NF1) might turn into a dangerous, hard-to-treat cancer called MPNST. Researchers will follow 80 participants considered at high risk, using annual whole-body MRI scan…

Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS)

Sponsor: Johns Hopkins University • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:32 UTC

MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS)

Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) OF SOFT TISSUE (DIAGNOSIS) trials appear

Hunting the clues: can scans predict deadly cancer in genetic disorder?